Federated Hermes Inc. Boosts Holdings in Astera Labs, Inc. $ALAB

Federated Hermes Inc. raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 91.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 278,305 shares of the company’s stock after buying an additional 133,305 shares during the period. Federated Hermes Inc. owned about 0.17% of Astera Labs worth $54,492,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. State Street Corp lifted its position in Astera Labs by 39.3% during the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after purchasing an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. grew its holdings in Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after purchasing an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA increased its position in Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after buying an additional 479,360 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Astera Labs by 36.2% in the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after buying an additional 330,841 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares of the company’s stock, valued at $27,823,452.93. This represents a 5.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 576,936 shares of company stock valued at $87,409,540 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on ALAB shares. BNP Paribas Exane started coverage on Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating for the company. Roth Mkm upped their price target on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. TD Cowen reissued a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Northland Securities lifted their target price on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Finally, Royal Bank Of Canada initiated coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $190.63.

Astera Labs Stock Performance

ALAB stock opened at $160.46 on Friday. The company’s fifty day moving average price is $163.81 and its 200-day moving average price is $170.73. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a market capitalization of $27.10 billion, a PE ratio of 144.56, a price-to-earnings-growth ratio of 2.29 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s revenue for the quarter was up 103.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.